{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:01:59Z","timestamp":1789693319246,"version":"4.0.1"},"reference-count":190,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI075549"],"award-info":[{"award-number":["U01 AI075549"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21\/R33AI101329"],"award-info":[{"award-number":["R21\/R33AI101329"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioDrugs"],"DOI":"10.1007\/s40259-026-00811-y","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:23:24Z","timestamp":1789644204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plant-Based Systems for Producing Therapeutic Proteins: Current Status and Future Prospects"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1498-7013","authenticated-orcid":false,"given":"Qiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"issue":"4","key":"811_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-024-03958-z","volume":"14","author":"V Kumar","year":"2024","unstructured":"Kumar V, Barwal A, Sharma N, Mir DS, Kumar P, Kumar V. Therapeutic proteins: developments, progress, challenges, and future perspectives. 3 Biotech. 2024;14(4):112.","journal-title":"3 Biotech"},{"issue":"1","key":"811_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-019-0592-z","volume":"27","author":"RM Lu","year":"2020","unstructured":"Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, et al. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci. 2020;27(1):1.","journal-title":"J Biomed Sci"},{"issue":"11","key":"811_CR3","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/nbt1026","volume":"22","author":"F Wurm","year":"2004","unstructured":"Wurm F. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol. 2004;22(11):1393\u20138.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"811_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12033-024-01060-6","volume":"67","author":"S Majumdar","year":"2025","unstructured":"Majumdar S, Desai R, Hans A, Dandekar P, Jain R. From efficiency to yield: exploring recent advances in CHO cell line development for monoclonal antibodies. Mol Biotechnol. 2025;67(2):369\u201392.","journal-title":"Mol Biotechnol"},{"key":"811_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2020.107552","volume":"43","author":"R O'Flaherty","year":"2020","unstructured":"O\u2019Flaherty R, Bergin A, Flampouri E, Martins Mota L, Obaidi I, Quigley A, et al. Mammalian cell culture for production of recombinant proteins: a review of the critical steps in their biomanufacturing. Biotechnol Adv. 2020;43:107552.","journal-title":"Biotechnol Adv"},{"key":"811_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1201\/b10952-5","volume-title":"Transgenic horticultural crops: challenges and opportunities\u2014essays by experts","author":"Q Chen","year":"2011","unstructured":"Chen Q. Expression and manufacture of pharmaceutical proteins in genetically engineered horticultural plants. In: Mou B, Scorza R, editors. Transgenic horticultural crops: challenges and opportunities\u2014essays by experts. Boca Raton: Taylor & Francis; 2011. p. 83\u2013124."},{"issue":"4","key":"811_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.13031\/2013.26854","volume":"1","author":"Q Chen","year":"2008","unstructured":"Chen Q. Expression and purification of pharmaceutical proteins in plants. Biol Eng. 2008;1(4):291\u2013321.","journal-title":"Biol Eng"},{"issue":"1","key":"811_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2026.2643039","volume":"18","author":"J Bravo-Venegas","year":"2026","unstructured":"Bravo-Venegas J, Rodriguez-Siza J, Vergara M, Torres M, Dickson A, Toledo JR, et al. Impact of process parameters on IgG glycosylation in CHO systems: a comprehensive quantitative analysis. MAbs. 2026;18(1):2643039.","journal-title":"MAbs"},{"key":"811_CR9","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.8010.1","volume":"5","author":"Q Chen","year":"2016","unstructured":"Chen Q, Davis K. The potential of plants as a system for the development and production of human biologics. F1000Res. 2016;5:912. https:\/\/doi.org\/10.12688\/f1000research.8010.1.","journal-title":"F1000Res"},{"key":"811_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/bs.abr.2017.11.006","volume-title":"Advances in botanical research","author":"Q Chen","year":"2018","unstructured":"Chen Q. Recombinant therapeutic molecules produced in plants. In: Kuntz M, editor. Advances in botanical research, vol. 86. Academic Press; 2018. p. 207\u201344. https:\/\/doi.org\/10.1016\/bs.abr.2017.11.006."},{"key":"811_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/932161","volume":"2015","author":"Q Chen","year":"2015","unstructured":"Chen Q, Lai H. Gene delivery into plant cells for recombinant protein production. Biomed Res Int. 2015;2015:932161. https:\/\/doi.org\/10.1155\/2015\/932161.","journal-title":"Biomed Res Int"},{"issue":"2","key":"811_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/jcp.21423","volume":"216","author":"C Lico","year":"2008","unstructured":"Lico C, Chen Q, Santi L. Viral vectors for production of recombinant proteins in plants. J Cell Physiol. 2008;216(2):366\u201377.","journal-title":"J Cell Physiol"},{"key":"811_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2018.00081","volume":"6","author":"L Montero-Morales","year":"2018","unstructured":"Montero-Morales L, Steinkellner H. Advanced plant-based glycan engineering. Front Bioeng Biotechnol. 2018;6:81. https:\/\/doi.org\/10.3389\/fbioe.2018.00081.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"811_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13007-017-0179-1","volume":"13","author":"M Adem","year":"2017","unstructured":"Adem M, Beyene D, Feyissa T. Recent achievements obtained by chloroplast transformation. Plant Methods. 2017;13(1):30.","journal-title":"Plant Methods"},{"key":"811_CR15","volume-title":"Chloroplast structure and function","author":"B Chavez","year":"2023","unstructured":"Chavez B, Ornelas S, Cruz Q, Barriga C, Gallegos S, Figueroa B, et al. Chloroplasts: the future of large-scale protein production. In: Khan MS, editor., et al., Chloroplast structure and function. London: IntechOpen; 2023."},{"key":"811_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122312","volume":"302","author":"RJ Kulchar","year":"2023","unstructured":"Kulchar RJ, Singh R, Ding S, Alexander E, Leong KW, Daniell H. Delivery of biologics: topical administration. Biomaterials. 2023;302:122312.","journal-title":"Biomaterials"},{"issue":"6","key":"811_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s44222-023-00044-6","volume":"1","author":"L Eidenberger","year":"2023","unstructured":"Eidenberger L, Kogelmann B, Steinkellner H. Plant-based biopharmaceutical engineering. Nat Rev Bioeng. 2023;1(6):426\u201339.","journal-title":"Nat Rev Bioeng"},{"key":"811_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-1-4939-3289-4_4","volume":"1385","author":"Q Chen","year":"2016","unstructured":"Chen Q, Dent M, Hurtado J, Stahnke J, McNulty A, Leuzinger K, et al. Transient protein expression by agroinfiltration in lettuce. Methods Mol Biol. 2016;1385:55\u201367.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"811_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/pbi.70232","volume":"24","author":"M Harding","year":"2026","unstructured":"Harding M, Sainsbury F. Protein engineering strategies to optimise recombinant product synthesis and accumulation in Nicotiana benthamiana. Plant Biotechnol J. 2026;24(1):31\u201343.","journal-title":"Plant Biotechnol J"},{"key":"811_CR20","doi-asserted-by":"publisher","first-page":"50521","DOI":"10.3791\/50521","volume":"77","author":"K Leuzinger","year":"2013","unstructured":"Leuzinger K, Dent M, Hurtado J, Stahnke J, Lai H, Zhou X, et al. Efficient agroinfiltration of plants for high-level transient expression of recombinant proteins. J Vis Exp. 2013;77:50521. https:\/\/doi.org\/10.3791\/50521.","journal-title":"J Vis Exp"},{"issue":"17-18","key":"811_CR21","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.vaccine.2005.01.006","volume":"23","author":"Y Gleba","year":"2005","unstructured":"Gleba Y, Klimyuk V, Marillonnet S. Magnifection\u2014a new platform for expressing recombinant vaccines in plants. Vaccine. 2005;23(17\u201318):2042\u20138.","journal-title":"Vaccine"},{"issue":"4","key":"811_CR22","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1104\/pp.107.106377","volume":"145","author":"J Lindbo","year":"2007","unstructured":"Lindbo J. TRBO: a high-efficiency tobacco mosaic virus RNA-based overexpression vector. Plant Physiol. 2007;145(4):1232\u201340.","journal-title":"Plant Physiol"},{"issue":"8","key":"811_CR23","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/pbi.12412","volume":"13","author":"H Peyret","year":"2015","unstructured":"Peyret H, Lomonossoff GP. When plant virology met Agrobacterium: the rise of the deconstructed clones. Plant Biotechnol J. 2015;13(8):1121\u201335.","journal-title":"Plant Biotechnol J"},{"issue":"3","key":"811_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4161\/hv.7.3.14262","volume":"7","author":"Q Chen","year":"2011","unstructured":"Chen Q, He J, Phoolcharoen W, Mason HS. Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants. Hum Vaccin. 2011;7(3):331\u20138.","journal-title":"Hum Vaccin"},{"key":"811_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.coviro.2021.12.005","volume":"52","author":"Q Chen","year":"2022","unstructured":"Chen Q. Development of plant-made monoclonal antibodies against viral infections. Curr Opin Virol. 2022;52:148\u201360.","journal-title":"Curr Opin Virol"},{"issue":"12","key":"811_CR26","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1093\/annonc\/mdq256","volume":"21","author":"M Bendandi","year":"2010","unstructured":"Bendandi M, Marillonnet S, Kandzia R, Thieme F, Nickstadt A, Herz S, et al. Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin\u2019s lymphoma. Ann Oncol. 2010;21(12):2420\u20137.","journal-title":"Ann Oncol"},{"issue":"34","key":"811_CR27","doi-asserted-by":"publisher","first-page":"14061","DOI":"10.1073\/pnas.1102928108","volume":"108","author":"S Werner","year":"2011","unstructured":"Werner S, Breus O, Symonenko Y, Marillonnet S, Gleba Y. High-level recombinant protein expression in transgenic plants by using a double-inducible viral vector. Proc Natl Acad Sci USA. 2011;108(34):14061\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"811_CR28","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1105\/tpc.113.113944","volume":"25","author":"B Dugdale","year":"2013","unstructured":"Dugdale B, Mortimer CL, Kato M, James TA, Harding RM, Dale JL. In plant activation: an inducible, hyperexpression platform for recombinant protein production in plants. Plant Cell. 2013;25(7):2429\u201343.","journal-title":"Plant Cell"},{"key":"811_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2025.108526","volume":"79","author":"J Xu","year":"2025","unstructured":"Xu J, PerezSanchez P, Sadravi S. Unlocking the full potential of plant cell-based production for valuable proteins: challenges and innovative strategies. Biotechnol Adv. 2025;79:108526.","journal-title":"Biotechnol Adv"},{"issue":"8","key":"811_CR30","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/biot.201300424","volume":"9","author":"MK Mandal","year":"2014","unstructured":"Mandal MK, Fischer R, Schillberg S, Schiermeyer A. Inhibition of protease activity by antisense RNA improves recombinant protein production in Nicotiana tabacum cv. Bright Yellow 2 (BY-2) suspension cells. Biotechnol J. 2014;9(8):1065\u201373.","journal-title":"Biotechnol J"},{"issue":"7","key":"811_CR31","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00299-021-02693-6","volume":"40","author":"U Karki","year":"2021","unstructured":"Karki U, Fang H, Guo W, Unnold-Cofre C, Xu J. Cellular engineering of plant cells for improved therapeutic protein production. Plant Cell Rep. 2021;40(7):1087\u201399.","journal-title":"Plant Cell Rep"},{"key":"811_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/antib12030051","volume":"12","author":"K Meskova","year":"2023","unstructured":"Meskova K, Martonova K, Hrasnova P, Sinska K, Skrabanova M, Fialova L, et al. Cost-effective protein production in CHO cells following polyethylenimine-mediated gene delivery showcased by the production and crystallization of antibody Fabs. Antibodies (Basel). 2023;12:51. https:\/\/doi.org\/10.3390\/antib12030051.","journal-title":"Antibodies (Basel)"},{"issue":"8","key":"811_CR33","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1080\/19420862.2016.1227901","volume":"8","author":"S Nandi","year":"2016","unstructured":"Nandi S, Kwong AT, Holtz BR, Erwin RL, Marcel S, McDonald KA. Techno-economic analysis of a transient plant-based platform for monoclonal antibody production. MAbs. 2016;8(8):1456\u201366.","journal-title":"MAbs"},{"key":"811_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/256135","volume":"2014","author":"D Tuse","year":"2014","unstructured":"Tuse D, Tu T, McDonald K. Manufacturing economics of plant-made biologics: case studies in therapeutic and industrial enzymes. Biomed Res Int. 2014;2014:256135. https:\/\/doi.org\/10.1155\/2014\/256135.","journal-title":"Biomed Res Int"},{"issue":"1","key":"811_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4172\/atbm.1000103","volume":"1","author":"Q Chen","year":"2013","unstructured":"Chen Q, Lai H, Hurtado J, Stahnke J, Leuzinger K, Dent M. Agroinfiltration as an effective and scalable strategy of gene delivery for production of pharmaceutical proteins. Adv Tech Biol Med. 2013;1(1):103. https:\/\/doi.org\/10.4172\/atbm.1000103.","journal-title":"Adv Tech Biol Med."},{"issue":"5","key":"811_CR36","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/pbi.12299","volume":"13","author":"S Hahn","year":"2015","unstructured":"Hahn S, Giritch A, Bartels D, Bortesi L, Gleba Y. A novel and fully scalable Agrobacterium spray-based process for manufacturing cellulases and other cost-sensitive proteins in plants. Plant Biotechnol J. 2015;13(5):708\u201316.","journal-title":"Plant Biotechnol J"},{"key":"811_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2020.107681","volume":"46","author":"J Huebbers","year":"2021","unstructured":"Huebbers J, Buyel J. On the verge of the market - plant factories for the automated and standardized production of biopharmaceuticals. Biotechnol Adv. 2021;46:107681.","journal-title":"Biotechnol Adv"},{"key":"811_CR38","unstructured":"Gibbs D, Eifert J, Riley P, Wong K, Mathur P, Paul L. Detailed characterization and quantification of post translational modifications on AAV capsids produced in whole tobacco plants using peptide mapping and LC\u2013MS\/MS. In: ASGCT 2026 annual meeting, Philadelphia, PA, USA. 2026."},{"issue":"12","key":"811_CR39","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.carres.2008.01.036","volume":"343","author":"C DeCastro","year":"2008","unstructured":"DeCastro C, Molinaro A, Lanzetta R, Silipo A, Parrilli M. Lipopolysaccharide structures from Agrobacterium and Rhizobiaceae species. Carbohydr Res. 2008;343(12):1924\u201333. https:\/\/doi.org\/10.1016\/j.carres.2008.01.036.","journal-title":"Carbohydr Res"},{"key":"811_CR40","unstructured":"Chen Q, Yang M, Lai H. Reducing the toxicity of Agrobacterium endotoxin. US Patent 11,130,956 B2. 2021."},{"issue":"8","key":"811_CR41","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/mt.2016.115","volume":"24","author":"K Kwon","year":"2016","unstructured":"Kwon K, Daniell H. Oral delivery of protein drugs bioencapsulated in plant cells. Mol Ther. 2016;24(8):1342\u201350.","journal-title":"Mol Ther"},{"key":"811_CR42","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jbiotec.2025.12.016","volume":"410","author":"M Ehsasatvatan","year":"2026","unstructured":"Ehsasatvatan M, Kohnehrouz B. Lyophilized chloroplasts as molecular capsules: a scalable platform for stable and functional human \u03b1-lactalbumin production. J Biotechnol. 2026;410:266\u201375.","journal-title":"J Biotechnol"},{"issue":"2","key":"811_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.biologicals.2015.12.001","volume":"44","author":"M Czyz","year":"2016","unstructured":"Czyz M, Dembczynski R, Marecik R, Pniewski T. Stability of S-HBsAg in long-term stored lyophilised plant tissue. Biologicals. 2016;44(2):69\u201372.","journal-title":"Biologicals"},{"key":"811_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2023.108206","volume":"67","author":"F Rocamora","year":"2023","unstructured":"Rocamora F, Peralta AG, Shin S, Sorrentino J, Wu M, Toth EA, et al. Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies. Biotechnol Adv. 2023;67:108206.","journal-title":"Biotechnol Adv"},{"issue":"2","key":"811_CR45","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/19420862.2018.1551044","volume":"11","author":"R Wada","year":"2019","unstructured":"Wada R, Matsui M, Kawasaki M. Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms. MAbs. 2019;11(2):350\u201372.","journal-title":"MAbs"},{"issue":"6","key":"811_CR46","doi-asserted-by":"publisher","first-page":"a005462","DOI":"10.1101\/cshperspect.a005462","volume":"3","author":"A Varki","year":"2011","unstructured":"Varki A. Evolutionary forces shaping the Golgi glycosylation machinery: why cell surface glycans are universal to living cells. Cold Spring Harb Perspect Biol. 2011;3(6):a005462. https:\/\/doi.org\/10.1101\/cshperspect.a005462.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"8","key":"811_CR47","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/nbt.3280","volume":"33","author":"Z Yang","year":"2015","unstructured":"Yang Z, Wang S, Halim A, Schulz MA, Frodin M, Rahman SH, et al. Engineered CHO cells for production of diverse, homogeneous glycoproteins. Nat Biotechnol. 2015;33(8):842\u20134.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"811_CR48","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/pbi.12981","volume":"17","author":"J Jansing","year":"2019","unstructured":"Jansing J, Sack M, Augustine SM, Fischer R, Bortesi L. CRISPR\/Cas9-mediated knockout of six glycosyltransferase genes in Nicotiana benthamiana for the production of recombinant proteins lacking \u03b2-1,2-xylose and core \u03b1-1,3-fucose. Plant Biotechnol J. 2019;17(2):350\u201361.","journal-title":"Plant Biotechnol J"},{"key":"811_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.plaphy.2015.04.010","volume":"92","author":"J Schneider","year":"2015","unstructured":"Schneider J, Castilho A, Pabst M, Altmann F, Gruber C, Strasser R, et al. Characterization of plants expressing the human beta1,4-galactosyltransferase gene. Plant Physiol Biochem. 2015;92:39\u201347. https:\/\/doi.org\/10.1016\/j.plaphy.2015.04.010.","journal-title":"Plant Physiol Biochem"},{"issue":"34","key":"811_CR50","doi-asserted-by":"publisher","first-page":"9498","DOI":"10.1073\/pnas.1604371113","volume":"113","author":"S Kallolimath","year":"2016","unstructured":"Kallolimath S, Castilho A, Strasser R, Grunwald-Gruber C, Altmann F, Strubl S, et al. Engineering of complex protein sialylation in plants. Proc Natl Acad Sci USA. 2016;113(34):9498\u2013503.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"34","key":"811_CR51","doi-asserted-by":"publisher","first-page":"9404","DOI":"10.1073\/pnas.1610803113","volume":"113","author":"Q Chen","year":"2016","unstructured":"Chen Q. Glycoengineering of plants yields glycoproteins with polysialylation and other defined N-glycoforms. Proc Natl Acad Sci USA. 2016;113(34):9404\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"811_CR52","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/pbi.12702","volume":"15","author":"U Hanania","year":"2017","unstructured":"Hanania U, Ariel T, Tekoah Y, Fux L, Sheva M, Gubbay Y, et al. Establishment of a tobacco BY2 cell line devoid of plant-specific xylose and fucose as a platform for the production of biotherapeutic proteins. Plant Biotechnol J. 2017;15(9):1120\u20139.","journal-title":"Plant Biotechnol J"},{"key":"811_CR53","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3389\/fpls.2017.00403","volume":"8","author":"S Mercx","year":"2017","unstructured":"Mercx S, Smargiasso N, Chaumet F, De Pauw E, Boutry M, Navarre C. Inactivation of the beta(1,2)-xylosyltransferase and the alpha(1,3)-fucosyltransferase genes in Nicotiana tabacum BY-2 cells by a multiplex CRISPR\/Cas9 strategy results in glycoproteins without plant-specific glycans. Front Plant Sci. 2017;8:403. https:\/\/doi.org\/10.3389\/fpls.2017.00403.","journal-title":"Front Plant Sci"},{"issue":"3","key":"811_CR54","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11248-017-0013-6","volume":"26","author":"C Navarre","year":"2017","unstructured":"Navarre C, Smargiasso N, Duvivier L, Nader J, Far J, De Pauw E, et al. N-Glycosylation of an IgG antibody secreted by Nicotiana tabacum BY-2 cells can be modulated through co-expression of human \u03b2-1,4-galactosyltransferase. Transgenic Res. 2017;26(3):375\u201384.","journal-title":"Transgenic Res"},{"issue":"1","key":"811_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/pbi.70044","volume":"24","author":"S Dianatkhah","year":"2026","unstructured":"Dianatkhah S, Kogelmann B, Melnik S, Eminger F, Kallolimath S, Sun L, et al. A plant cell-based platform for the expression of complex proteins with fucose-reduced sialylated N-glycans. Plant Biotechnol J. 2026;24(1):93\u20135.","journal-title":"Plant Biotechnol J"},{"issue":"11","key":"811_CR56","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1111\/pbi.14429","volume":"22","author":"JH Shin","year":"2024","unstructured":"Shin JH, Oh S, Jang MH, Lee SY, Min C, Eu YJ, et al. Enhanced efficacy of glycoengineered rice cell-produced trastuzumab. Plant Biotechnol J. 2024;22(11):3068\u201381.","journal-title":"Plant Biotechnol J"},{"issue":"7","key":"811_CR57","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nbt.3556","volume":"34","author":"Y Shaaltiel","year":"2016","unstructured":"Shaaltiel Y, Tekoah T. Plant specific N-glycans do not have proven adverse effects in humans. Nat Biotechnol. 2016;34(7):706\u20138.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"811_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186211","volume":"12","author":"B Rup","year":"2017","unstructured":"Rup B, Alon S, Amit-Cohen BC, Brill Almon E, Chertkoff R, Tekoah Y, et al. Immunogenicity of glycans on biotherapeutic drugs produced in plant expression systems\u2014the taliglucerase alfa story. PLoS ONE. 2017;12(10):e0186211.","journal-title":"PLoS ONE"},{"issue":"1","key":"811_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02180-3","volume":"10","author":"W Zhu","year":"2024","unstructured":"Zhu W, Zhou Y, Guo L, Feng S. Biological function of sialic acid and sialylation in human health and disease. Cell Death Discov. 2024;10(1):415.","journal-title":"Cell Death Discov"},{"key":"811_CR60","doi-asserted-by":"publisher","unstructured":"Elstein D, Zimran A. Gaucher disease. In: Mehta AB, Winchester B, editors. Lysosomal storage disorders. John Wiley & Sons; 2022. p. 85\u201397. https:\/\/doi.org\/10.1002\/9781119697312.ch9.","DOI":"10.1002\/9781119697312.ch9"},{"key":"811_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020441","volume":"18","author":"J Stirnemann","year":"2017","unstructured":"Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, et al. A review of Gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci. 2017;18:441. https:\/\/doi.org\/10.3390\/ijms18020441.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"811_CR62","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1467-7652.2007.00263.x","volume":"5","author":"Y Shaaltiel","year":"2007","unstructured":"Shaaltiel Y, Bartfeld D, Hashmueli S, Baum G, Brill-Almon E, Galili G, et al. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher\u2019s disease using a plant cell system. Plant Biotechnol J. 2007;5(5):579\u201390.","journal-title":"Plant Biotechnol J"},{"issue":"22","key":"811_CR63","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1182\/blood-2011-07-366955","volume":"118","author":"A Zimran","year":"2011","unstructured":"Zimran A, Brill-Almon E, Chertkoff R, Petakov M, Blanco-Favela F, Terreros Munoz E, et al. Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. Blood. 2011;118(22):5767\u201373.","journal-title":"Blood"},{"issue":"1","key":"811_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02289-7","volume":"17","author":"L Titievsky","year":"2022","unstructured":"Titievsky L, Schuster T, Wang R, Younus M, Palladino A, Quazi K, et al. Safety and effectiveness of taliglucerase alfa in patients with Gaucher disease: an interim analysis of real-world data from a multinational drug registry (TALIAS). Orphanet J Rare Dis. 2022;17(1):145.","journal-title":"Orphanet J Rare Dis"},{"key":"811_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bcmd.2016.10.005","volume":"68","author":"A Zimran","year":"2018","unstructured":"Zimran A, Gonzalez-Rodriguez DE, Abrahamov A, Cooper PA, Varughese S, Giraldo P, et al. Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naive or previously treated with imiglucerase. Blood Cells Mol Dis. 2018;68:163\u201372.","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"811_CR66","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nbt0612-472","volume":"30","author":"J Fox","year":"2012","unstructured":"Fox J. First plant-made biologic approved. Nat Biotechnol. 2012;30(6):472\u2013472.","journal-title":"Nat Biotechnol"},{"key":"811_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1395287","volume":"15","author":"DP Germain","year":"2024","unstructured":"Germain DP, Linhart A. Pegunigalsidase alfa: a novel, pegylated recombinant alpha-galactosidase enzyme for the treatment of Fabry disease. Front Genet. 2024;15:1395287. https:\/\/doi.org\/10.3389\/fgene.2024.1395287.","journal-title":"Front Genet"},{"issue":"5","key":"811_CR68","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/jimd.12228","volume":"43","author":"SJ van der Veen","year":"2020","unstructured":"van der Veen SJ, Hollak CEM, van Kuilenburg ABP, Langeveld M. Developments in the treatment of Fabry disease. J Inherit Metab Dis. 2020;43(5):908\u201321.","journal-title":"J Inherit Metab Dis"},{"key":"811_CR69","unstructured":"ClinicalTrials.gov. A study to evaluate the safety, tolerability, PK, and PD properties of PRX-115 in adult volunteers with elevated uric acid levels. ClinicalTrials.gov Identifier NCT05745727. Updated 1 July 2026. Accessed 26 Aug 2026."},{"issue":"8","key":"811_CR70","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/pbi.12366","volume":"13","author":"Y Shaaltiel","year":"2015","unstructured":"Shaaltiel Y, Gingis-Velitski S, Tzaban S, Fiks N, Tekoah Y, Aviezer D. Plant-based oral delivery of \u03b2-glucocerebrosidase as an enzyme replacement therapy for Gaucher\u2019s disease. Plant Biotechnol J. 2015;13(8):1033\u201340.","journal-title":"Plant Biotechnol J"},{"issue":"1","key":"811_CR71","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2009.09.002","volume":"99","author":"T Kang","year":"2010","unstructured":"Kang T, Wang L, Sarkissian C, Gamez A, Scriver C, Stevens R. Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria. Mol Genet Metab. 2010;99(1):4\u20139.","journal-title":"Mol Genet Metab"},{"issue":"8","key":"811_CR72","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/pbi.12433","volume":"13","author":"JL Fuqua","year":"2015","unstructured":"Fuqua JL, Hamorsky K, Khalsa G, Matoba N, Palmer KE. Bulk production of the antiviral lectin griffithsin. Plant Biotechnol J. 2015;13(8):1160\u20138.","journal-title":"Plant Biotechnol J"},{"issue":"9","key":"811_CR73","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-073735","volume":"13","author":"E Cash","year":"2023","unstructured":"Cash E, Deitz K, Potts KL, Nabeta HW, Zahin M, Rai SN, et al. Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL). BMJ Open. 2023;13(9):e073735.","journal-title":"BMJ Open"},{"issue":"4","key":"811_CR74","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1600-0684.2007.00242.x","volume":"36","author":"P Emau","year":"2007","unstructured":"Emau P, Tian B, O\u2019keefe B, Mori T, McMahon J, Palmer K, et al. Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide. J Med Primatol. 2007;36(4):244\u201353.","journal-title":"J Med Primatol"},{"issue":"1","key":"811_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261775","volume":"17","author":"N Teleshova","year":"2022","unstructured":"Teleshova N, Keller MJ, Fernandez Romero JA, Friedland BA, Creasy GW, Plagianos MG, et al. Results of a phase 1, randomized, placebo-controlled first-in-human trial of griffithsin formulated in a carrageenan vaginal gel. PLoS ONE. 2022;17(1):e0261775. https:\/\/doi.org\/10.1371\/journal.pone.0261775.","journal-title":"PLoS ONE"},{"issue":"1","key":"811_CR76","doi-asserted-by":"publisher","first-page":"22","DOI":"10.55504\/2473-2869.1250","volume":"6","author":"HW Nabeta","year":"2022","unstructured":"Nabeta HW, Zahin M, Fuqua JL, Cash ED, Leth I, Strauss M, et al. A phase 1a\/1b clinical trial design to assess safety, acceptability, pharmacokinetics and tolerability of intranasal Q-Griffithsin for COVID-19 prophylaxis. Univ Louisville J Respir Infect. 2022;6(1):22. https:\/\/doi.org\/10.55504\/2473-2869.1250.","journal-title":"Univ Louisville J Respir Infect."},{"key":"811_CR77","unstructured":"BioVIA. SwiftPharma announces partnership with Medicines Patent Pool and Population Council on Project ELYRA to expand pathways for Griffithsin-based STI prevention. 2026. https:\/\/www.biovia.be\/news\/swiftpharma-announces-partnership-medicines-patent-pool-and-population-council-project-elyra. Accessed 26 Aug 2026."},{"issue":"3","key":"811_CR78","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1128\/AAC.45.3.664-672.2001","volume":"45","author":"T Mori","year":"2001","unstructured":"Mori T, Boyd M. Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells. Antimicrob Agents Chemother. 2001;45(3):664\u201372.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"811_CR79","doi-asserted-by":"publisher","first-page":"139","DOI":"10.15171\/bi.2018.16","volume":"8","author":"H Lotfi","year":"2018","unstructured":"Lotfi H, Sheervalilou R, Arghami N. An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development. Bioimpacts. 2018;8(2):139\u201351.","journal-title":"Bioimpacts"},{"issue":"2","key":"811_CR80","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1096\/fj.05-4742fje","volume":"20","author":"A Sexton","year":"2006","unstructured":"Sexton A, Drake PM, Mahmood N, Harman SJ, Shattock RJ, Ma JKC. Transgenic plant production of Cyanovirin-N, an HIV microbicide. FASEB J. 2006;20(2):356\u20138.","journal-title":"FASEB J"},{"issue":"6","key":"811_CR81","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00299-016-1963-5","volume":"35","author":"E Vamvaka","year":"2016","unstructured":"Vamvaka E, Evans A, Ramessar K, Krumpe LRH, Shattock RJ, O\u2019Keefe BR, et al. Cyanovirin-N produced in rice endosperm offers effective pre-exposure prophylaxis against HIV-1BaL infection in vitro. Plant Cell Rep. 2016;35(6):1309\u201319.","journal-title":"Plant Cell Rep"},{"issue":"7","key":"811_CR82","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1089\/088922203322230897","volume":"19","author":"CC Tsai","year":"2003","unstructured":"Tsai CC, Emau P, Jiang Y, Tian B, Morton WR, Gustafson KR, et al. Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques. AIDS Res Hum Retroviruses. 2003;19(7):535\u201341.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"40","key":"811_CR83","doi-asserted-by":"publisher","first-page":"E5454","DOI":"10.1073\/pnas.1513311112","volume":"112","author":"S Schulz","year":"2015","unstructured":"Schulz S, Stephan A, Hahn S, Bortesi L, Jarczowski F, Bettmann U, et al. Broad and efficient control of major foodborne pathogenic strains of Escherichia coli by mixtures of plant-produced colicins. Proc Natl Acad Sci USA. 2015;112(40):E5454\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"811_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2023.1271757","volume":"14","author":"N Shcherbak","year":"2023","unstructured":"Shcherbak N, Prochaska H, Lystvan K, Prokhorova Y, Giritch A, Kuchuk M. Accumulation of colicin M protein and its biological activity in transgenic lettuce and mizuna plants. Front Plant Sci. 2023;14:1271757. https:\/\/doi.org\/10.3389\/fpls.2023.1271757.","journal-title":"Front Plant Sci"},{"issue":"1","key":"811_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22465-9","volume":"8","author":"T Schneider","year":"2018","unstructured":"Schneider T, Hahn-Lobmann S, Stephan A, Schulz S, Giritch A, Naumann M, et al. Plant-made Salmonella bacteriocins salmocins for control of Salmonella pathovars. Sci Rep. 2018;8(1):4078.","journal-title":"Sci Rep"},{"key":"811_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2019.00437","volume":"10","author":"S Hahn-Lobmann","year":"2019","unstructured":"Hahn-Lobmann S, Stephan A, Schulz S, Schneider T, Shaverskyi A, Tuse D, et al. Colicins and salmocins\u2014new classes of plant-made non-antibiotic food antibacterials. Front Plant Sci. 2019;10:437. https:\/\/doi.org\/10.3389\/fpls.2019.00437.","journal-title":"Front Plant Sci"},{"key":"811_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2022.104641","volume":"382","author":"J Rana","year":"2022","unstructured":"Rana J, Mu\u00f1oz M, Biswas M. Oral tolerance to prevent anti-drug antibody formation in protein replacement therapies. Cell Immunol. 2022;382:104641.","journal-title":"Cell Immunol"},{"issue":"1","key":"811_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autrev.2009.02.024","volume":"9","author":"J Peron","year":"2009","unstructured":"Peron J, Ligeiro de Oliveira A, Rizzo L. It takes guts for tolerance: the phenomenon of oral tolerance and the regulation of autoimmune response. Autoimmun Rev. 2009;9(1):1\u20134.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"811_CR89","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.imbio.2016.11.001","volume":"222","author":"Y Ilan","year":"2017","unstructured":"Ilan Y, Gingis-Velitski S, Ben Ya\u2019acov A, Shabbat Y, Zolotarov L, Almon E, et al. A plant cell-expressed recombinant anti-TNF fusion protein is biologically active in the gut and alleviates immune-mediated hepatitis and colitis. Immunobiology. 2017;222(3):544\u201351.","journal-title":"Immunobiology"},{"issue":"39","key":"811_CR90","doi-asserted-by":"publisher","first-page":"8760","DOI":"10.3748\/wjg.v22.i39.8760","volume":"22","author":"Y Ilan","year":"2016","unstructured":"Ilan Y, Ben Ya\u2019acov A, Shabbat Y, Gingis-Velitski S, Almon E, Shaaltiel Y. Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis. World J Gastroenterol. 2016;22(39):8760\u20139.","journal-title":"World J Gastroenterol"},{"key":"811_CR91","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jim.2017.03.023","volume":"446","author":"E Almon","year":"2017","unstructured":"Almon E, Khoury T, Drori A, Gingis-Velitski S, Alon S, Chertkoff R, et al. An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy. J Immunol Methods. 2017;446:21\u20139.","journal-title":"J Immunol Methods"},{"issue":"2","key":"811_CR92","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/MCG.0000000000001314","volume":"55","author":"E Almon","year":"2021","unstructured":"Almon E, Shaaltiel Y, Sbeit W, Fich A, Schwartz D, Waterman M, et al. Novel orally administered recombinant anti-TNF alpha fusion protein for the treatment of ulcerative colitis: results from a phase 2a clinical trial. J Clin Gastroenterol. 2021;55(2):134\u201340. https:\/\/doi.org\/10.1097\/MCG.0000000000001314.","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"811_CR93","doi-asserted-by":"publisher","first-page":"107413","DOI":"10.1016\/j.biotechadv.2019.06.012","volume":"37","author":"H Daniell","year":"2019","unstructured":"Daniell H, Kulis M, Herzog R. Plant cell-made protein antigens for induction of oral tolerance. Biotechnol Adv. 2019;37(7):107413.","journal-title":"Biotechnol Adv"},{"issue":"8","key":"811_CR94","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/pbi.12413","volume":"13","author":"J Su","year":"2015","unstructured":"Su J, Sherman A, Doerfler P, Byrne B, Herzog R, Daniell H. Oral delivery of acid alpha glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice. Plant Biotechnol J. 2015;13(8):1023\u201332.","journal-title":"Plant Biotechnol J"},{"issue":"10","key":"811_CR95","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1182\/blood-2013-10-528737","volume":"124","author":"A Sherman","year":"2014","unstructured":"Sherman A, Su J, Lin S, Wang X, Herzog R, Daniell H. Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells. Blood. 2014;124(10):1659\u201368.","journal-title":"Blood"},{"issue":"6245","key":"811_CR96","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/342076a0","volume":"342","author":"A Hiatt","year":"1989","unstructured":"Hiatt A, Cafferkey R, Bowdish K. Production of antibodies in transgenic plants. Nature. 1989;342(6245):76\u20138.","journal-title":"Nature"},{"key":"811_CR97","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1079\/9781780643434.0042","volume-title":"Plant-derived pharmaceuticals: principles and applications for developing countries","author":"Q Chen","year":"2014","unstructured":"Chen Q, Lai H. Plant-derived monoclonal antibodies as human biologics for infectious disease and cancer. In: Hefferon KL, editor. Plant-derived pharmaceuticals: principles and applications for developing countries. Cryodon: CABI; 2014. p. 42\u201375."},{"issue":"1","key":"811_CR98","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/pbi.13194","volume":"18","author":"J Hurtado","year":"2020","unstructured":"Hurtado J, Acharya D, Lai H, Sun H, Kallolimath S, Steinkellner H, et al. In vitro and in vivo efficacy of anti-chikungunya virus monoclonal antibodies produced in wild-type and glycoengineered Nicotiana benthamiana plants. Plant Biotechnol J. 2020;18(1):266\u201373.","journal-title":"Plant Biotechnol J"},{"issue":"17","key":"811_CR99","doi-asserted-by":"publisher","first-page":"6263","DOI":"10.1073\/pnas.1320544111","volume":"111","author":"A Loos","year":"2014","unstructured":"Loos A, Gruber C, Altmann F, Mehofer U, Hensel F, Grandits M, et al. Expression and glycoengineering of functionally active heteromultimeric IgM in plants. Proc Natl Acad Sci USA. 2014;111(17):6263\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"811_CR100","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.4161\/mabs.36336","volume":"6","author":"M Paul","year":"2014","unstructured":"Paul M, Reljic R, Klein K, Drake PMW, van Dolleweerd C, Pabst M, et al. Characterization of a plant-produced recombinant human secretory IgA with broad neutralizing activity against HIV. MAbs. 2014;6(6):1585\u201397.","journal-title":"MAbs"},{"key":"811_CR101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1147960","volume":"14","author":"S Kallolimath","year":"2023","unstructured":"Kallolimath S, Palt R, Foderl-Hobenreich E, Sun L, Chen Q, Pruckner F, et al. Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues. Front Immunol. 2023;14:1147960. https:\/\/doi.org\/10.3389\/fimmu.2023.1147960.","journal-title":"Front Immunol"},{"key":"811_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125510","volume":"26","author":"SA Akher","year":"2025","unstructured":"Akher SA, Wang KY, Hall K, Hunpatin OS, Shan M, Zhang Z, et al. Harnessing transient expression systems with plant viral vectors for the production of biopharmaceuticals in Nicotiana benthamiana. Int J Mol Sci. 2025;26:5510. https:\/\/doi.org\/10.3390\/ijms26125510.","journal-title":"Int J Mol Sci"},{"issue":"40","key":"811_CR103","doi-asserted-by":"publisher","first-page":"14701","DOI":"10.1073\/pnas.0606631103","volume":"103","author":"A Giritch","year":"2006","unstructured":"Giritch A, Marillonnet S, Engler C, van Eldik G, Botterman J, Klimyuk V, et al. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc Natl Acad Sci USA. 2006;103(40):14701\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"811_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2014.00523","volume":"5","author":"A Loos","year":"2014","unstructured":"Loos A, Steinkellner H. Plant glyco-biotechnology on the way to synthetic biology. Front Plant Sci. 2014;5:523. https:\/\/doi.org\/10.3389\/fpls.2014.00523.","journal-title":"Front Plant Sci"},{"key":"811_CR105","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-1-0716-2835-5_17","volume-title":"Chemokine-glycosaminoglycan interactions: methods and protocols","author":"A Esqueda","year":"2023","unstructured":"Esqueda A, Chen Q. Producing biologics with defined N-glycosylation in plants. In: Lucas AR, editor. Chemokine-glycosaminoglycan interactions: methods and protocols. New York: Springer US; 2023. p. 235\u201350."},{"issue":"3","key":"811_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093541","volume":"9","author":"J He","year":"2014","unstructured":"He J, Lai H, Engle M, Gorlatov S, Gruber C, Steinkellner H, et al. Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus. PLoS ONE. 2014;9(3):e93541. https:\/\/doi.org\/10.1371\/journal.pone.0093541.","journal-title":"PLoS ONE"},{"issue":"8","key":"811_CR107","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/pbi.12217","volume":"12","author":"H Lai","year":"2014","unstructured":"Lai H, He J, Hurtado J, Stahnke J, Fuchs A, Mehlhop E, et al. Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants. Plant Biotechnol J. 2014;12(8):1098\u2013107.","journal-title":"Plant Biotechnol J"},{"key":"811_CR108","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/106783","author":"J He","year":"2012","unstructured":"He J, Lai H, Brock C, Chen Q. A novel system for rapid and cost-effective production of detection and diagnostic reagents of West Nile virus in plants. J Biomed Biotechnol. 2012. https:\/\/doi.org\/10.1155\/2012\/106783.","journal-title":"J Biomed Biotechnol"},{"issue":"6","key":"811_CR109","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1073\/pnas.0914503107","volume":"107","author":"H Lai","year":"2010","unstructured":"Lai H, Engle M, Fuchs A, Keller T, Johnson S, Gorlatov S, et al. Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice. Proc Natl Acad Sci USA. 2010;107(6):2419\u201324.","journal-title":"Proc Natl Acad Sci USA"},{"key":"811_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2020.612781","volume":"11","author":"B Diego-Martin","year":"2020","unstructured":"Diego-Martin B, Gonzalez B, Vazquez-Vilar M, Selma S, Mateos-Fernandez R, Gianoglio S, et al. Pilot production of SARS-CoV-2 related proteins in plants: a proof of concept for rapid repurposing of indoor farms into biomanufacturing facilities. Front Plant Sci. 2020;11:612781.","journal-title":"Front Plant Sci"},{"issue":"5","key":"811_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050772","volume":"10","author":"C Jugler","year":"2022","unstructured":"Jugler C, Sun H, Grill F, Kibler K, Esqueda A, Lai H, et al. Potential for a plant-made SARS-CoV-2 neutralizing monoclonal antibody as a synergetic cocktail component. Vaccines. 2022;10(5):772. https:\/\/doi.org\/10.3390\/vaccines10050772.","journal-title":"Vaccines"},{"key":"811_CR112","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/pbi.13970","volume":"21","author":"C Jugler","year":"2023","unstructured":"Jugler C, Sun H, Nguyen K, Palt R, Felder M, Steinkellner H, et al. A novel plant-made monoclonal antibody enhances the synergetic potency of an antibody cocktail against the SARS-CoV-2 Omicron variant. Plant Biotechnol J. 2023;21:549\u201359.","journal-title":"Plant Biotechnol J"},{"issue":"6","key":"811_CR113","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41577-021-00542-x","volume":"21","author":"P Taylor","year":"2021","unstructured":"Taylor P, Adams A, Hufford M, Torre I, Winthrop K, Gottieb R. Neutralizing monoclonal antibodies for treatment of COVID-19. Nat Rev Immunol. 2021;21(6):382\u201393.","journal-title":"Nat Rev Immunol"},{"key":"811_CR114","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/pbi.13980","volume":"21","author":"H Sun","year":"2023","unstructured":"Sun H, Jugler C, Nguyen K, Steinkellner H, Chen Q. The potency and synergy of plant-made monoclonal antibodies against the BA.5 variant of SARS-CoV-2. Plant Biotechnol J. 2023;21:463\u20135.","journal-title":"Plant Biotechnol J"},{"issue":"44","key":"811_CR115","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2107148118","volume":"118","author":"L Sun","year":"2021","unstructured":"Sun L, Kallolimath S, Palt R, Stiasny K, Mayrhofer P, Maresch D, et al. Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG. Proc Natl Acad Sci USA. 2021;118(44):e2107148118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"42","key":"811_CR116","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2107249118","volume":"118","author":"S Kallolimath","year":"2021","unstructured":"Kallolimath S, Sun L, Palt R, Stiasny K, Mayrhofer P, Bruber C, et al. Highly active engineered IgG3 antibodies against SARS-CoV-2. Proc Natl Acad Sci USA. 2021;118(42):e2107249118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"811_CR117","doi-asserted-by":"crossref","unstructured":"Sun H, Esqueda A, Steinkellner H, Chen Q. Role of nonneutralizing antibodies and Fc effector functions in inhibiting SARS-CoV-2 infection. bioRxiv, 2026: 2026.04.08.717316.","DOI":"10.64898\/2026.04.08.717316"},{"issue":"11","key":"811_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9111365","volume":"9","author":"C Jugler","year":"2021","unstructured":"Jugler C, Sun H, Chen Q. SARS-CoV-2 spike protein-induced interleukin 6 signaling is blocked by a plant-produced anti-interleukin 6 receptor monoclonal antibody. Vaccines (Basel). 2021;9(11):1365.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"811_CR119","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/bit.22652","volume":"106","author":"Z Huang","year":"2010","unstructured":"Huang Z, Phoolcharoen W, Lai H, Piensook K, Cardineau G, Zeitlin L, et al. High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system. Biotechnol Bioeng. 2010;106(1):9\u201317.","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"811_CR120","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1467-7652.2011.00649.x","volume":"10","author":"H Lai","year":"2012","unstructured":"Lai H, He J, Engle M, Gruber C, Gorlatov S, Chen Q. Robust production of virus-like particles and monoclonal antibodies with geminiviral replicon vectors in lettuce. Plant Biotechnol J. 2012;10(1):95\u2013104.","journal-title":"Plant Biotechnol J"},{"issue":"0","key":"811_CR121","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.chroma.2015.02.013","volume":"1389","author":"A Fulton","year":"2015","unstructured":"Fulton A, Lai H, Chen Q, Zhang C. Purification of monoclonal antibody against Ebola GP1 protein expressed in Nicotiana benthamiana. J Chromatogr A. 2015;1389(0):128\u201332.","journal-title":"J Chromatogr A"},{"key":"811_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/nature.2014.15698","author":"E Check Hayden","year":"2014","unstructured":"Check Hayden E, Reardon S. Should experimental drugs be used in the Ebola outbreak? Nature. 2014. https:\/\/doi.org\/10.1038\/nature.2014.15698.","journal-title":"Nature"},{"issue":"51","key":"811_CR123","doi-asserted-by":"publisher","first-page":"20690","DOI":"10.1073\/pnas.1108360108","volume":"108","author":"L Zeitlin","year":"2011","unstructured":"Zeitlin L, Pettitt J, Scully C, Bohorova N, Kim D, Pauly M, et al. Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proc Natl Acad Sci USA. 2011;108(51):20690\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"44","key":"811_CR124","doi-asserted-by":"publisher","first-page":"18030","DOI":"10.1073\/pnas.1213709109","volume":"109","author":"G Olinger","year":"2012","unstructured":"Olinger G, Pettitt J, Kim D, Working C, Bohorov O, Bracher B, et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci USA. 2012;109(44):18030\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7520","key":"811_CR125","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature13777","volume":"514","author":"X Qiu","year":"2014","unstructured":"Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature. 2014;514(7520):47\u201353.","journal-title":"Nature"},{"issue":"15","key":"811_CR126","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","volume":"375","author":"The PREVAIL II Writing Group","year":"2016","unstructured":"The PREVAIL II Writing Group. A randomized, controlled trial of ZMapp for Ebola virus infection. N Engl J Med. 2016;375(15):1448\u201356.","journal-title":"N Engl J Med"},{"issue":"24","key":"811_CR127","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","volume":"381","author":"S Mulangu","year":"2019","unstructured":"Mulangu S, Dodd L, Davey R, Mbaya O, Proschan M, Mukadi D, et al. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med. 2019;381(24):2293\u2013303.","journal-title":"N Engl J Med"},{"key":"811_CR128","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/clinids\/19.3.500","volume":"19","author":"D Morens","year":"1994","unstructured":"Morens D. Antibody-dependent of enhancement of infection and the pathogenesis of viral disease. Clin Inf Dis. 1994;19:500\u201312.","journal-title":"Clin Inf Dis."},{"issue":"1","key":"811_CR129","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/imr.12367","volume":"268","author":"A Taylor","year":"2015","unstructured":"Taylor A, Foo SS, Bruzzone R, Vu Dinh L, King NJC, Mahalingam S. Fc receptors in antibody-dependent enhancement of viral infections. Immunol Rev. 2015;268(1):340\u201364.","journal-title":"Immunol Rev"},{"issue":"6","key":"811_CR130","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/rmv.405","volume":"13","author":"A Takada","year":"2003","unstructured":"Takada A, Kawaoka Y. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol. 2003;13(6):387\u201398.","journal-title":"Rev Med Virol"},{"key":"811_CR131","first-page":"299","volume":"5","author":"A Murray","year":"2013","unstructured":"Murray A, Quam M, Wilder-Smith A. Epidemiology of dengue: past, present and future prospects. Clin Epidemiol. 2013;5:299\u2013309.","journal-title":"Clin Epidemiol"},{"issue":"7","key":"811_CR132","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1172\/JCI21512","volume":"113","author":"L Rothman","year":"2004","unstructured":"Rothman L. Dengue: defining protective versus pathologic immunity. J Clin Investig. 2004;113(7):946\u201351.","journal-title":"J Clin Investig"},{"issue":"9599","key":"811_CR133","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","volume":"370","author":"S Halstead","year":"2007","unstructured":"Halstead S. Dengue. Lancet. 2007;370(9599):1644\u201352.","journal-title":"Lancet"},{"issue":"12","key":"811_CR134","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1099\/jgv.0.000635","volume":"97","author":"M Dent","year":"2016","unstructured":"Dent M, Hurtado J, Paul AM, Sun H, Lai H, Yang M, et al. Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity. J Gen Virol. 2016;97(12):3280\u201390.","journal-title":"J Gen Virol"},{"issue":"4","key":"811_CR135","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.chom.2009.09.003","volume":"6","author":"E Mehlhop","year":"2009","unstructured":"Mehlhop E, Nelson S, Jost C, Gorlatov S, Johnson S, Fremont D, et al. Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus. Cell Host Microbe. 2009;6(4):381\u201391.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"811_CR136","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jcv.2006.04.010","volume":"37","author":"G Garcia","year":"2006","unstructured":"Garcia G, Arango M, Perez AB, Fonte L, Sierra B, Rodriguez-Roche R, et al. Antibodies from patients with dengue viral infection mediate cellular cytotoxicity. J Clin Virol. 2006;37(1):53\u20137.","journal-title":"J Clin Virol"},{"issue":"8","key":"811_CR137","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1086\/512860","volume":"195","author":"K Laoprasopwattana","year":"2007","unstructured":"Laoprasopwattana K, Libraty DH, Endy TP, Nisalak A, Chunsuttiwat S, Ennis FA, et al. Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication. J Infect Dis. 2007;195(8):1108\u201316.","journal-title":"J Infect Dis"},{"key":"811_CR138","unstructured":"Chen Q, Lai H, Hurtado J. Plant-derived antibodies and derivatives that reduce risk of antibody-dependent enhancement (ADE) of infection. US Patent 10,982,221. 2021."},{"issue":"1","key":"811_CR139","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010054","volume":"19","author":"H Sun","year":"2018","unstructured":"Sun H, Chen Q, Lai H. Development of antibody therapeutics against flaviviruses. Int J Mol Sci. 2018;19(1):54.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"811_CR140","volume":"13","author":"A Alli","year":"2021","unstructured":"Alli A, Ortiz F, Atoot A, Atoot A, Millhouse P. Management of West Nile encephalitis: an uncommon complication of West Nile virus. Cureus. 2021;13(2):e13183.","journal-title":"Cureus"},{"issue":"3","key":"811_CR141","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1001\/jama.2013.8042","volume":"310","author":"R Petersen","year":"2013","unstructured":"Petersen R, Brault C, Nasci R. West Nile virus: review of the literature. JAMA. 2013;310(3):308\u201315.","journal-title":"JAMA"},{"issue":"3","key":"811_CR142","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093541","volume":"9","author":"J He","year":"2014","unstructured":"He J, Lai H, Engle M, Gorlatov S, Gruber C, Steinkellner H, et al. Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus. PLoS ONE. 2014;9(3):e93541.","journal-title":"PLoS ONE"},{"issue":"2","key":"811_CR143","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/bit.21120","volume":"96","author":"RJ Boado","year":"2007","unstructured":"Boado RJ, Zhang Y, Zhang Y, Pardridge WM. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood\u2013brain barrier. Biotechnol Bioeng. 2007;96(2):381\u201391.","journal-title":"Biotechnol Bioeng"},{"issue":"3","key":"811_CR144","doi-asserted-by":"publisher","first-page":"e2137","DOI":"10.1371\/journal.pntd.0002137","volume":"7","author":"C Schilte","year":"2013","unstructured":"Schilte C, Staikowsky F, Couderc T, Madec Y, Carpentier F, Kassab S, et al. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7(3):e2137\u2013e2137.","journal-title":"PLoS Negl Trop Dis"},{"key":"811_CR145","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.antiviral.2015.04.016","volume":"120","author":"S Weaver","year":"2015","unstructured":"Weaver S, Forrester N. Chikungunya: evolutionary history and recent epidemic spread. Antivir Res. 2015;120:32\u20139.","journal-title":"Antivir Res"},{"issue":"4","key":"811_CR146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003312","volume":"9","author":"P Pal","year":"2013","unstructured":"Pal P, Dowd KA, Brien JD, Edeling MA, Gorlatov S, Johnson S, et al. Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus. PLoS Pathog. 2013;9(4):e1003312.","journal-title":"PLoS Pathog"},{"key":"811_CR147","unstructured":"Chen Q, Lai H, Hurtado J. Plant-produced mAbs against chikungunya virus with enhanced effector function and efficacy. International Patent Application PCT\/US2020\/036136. 2020."},{"key":"811_CR148","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/bs.mie.2021.05.003","volume-title":"Recombinant protein expression: eukaryotic hosts","author":"A Esqueda","year":"2021","unstructured":"Esqueda A, Jugler C, Chen Q. Design and expression of a bispecific antibody against dengue and chikungunya virus in plants. In: O\u2019Dell WB, Kelman Z, editors. Recombinant protein expression: eukaryotic hosts, vol. 660. Academic Press; 2021. p. 223\u201338. https:\/\/doi.org\/10.1016\/bs.mie.2021.05.003."},{"issue":"11","key":"811_CR149","doi-asserted-by":"publisher","first-page":"6876","DOI":"10.4049\/jimmunol.1002600","volume":"185","author":"D Forthal","year":"2010","unstructured":"Forthal D, Gach J, Landucci G, Jez J, Strasser R, Kunert R, et al. Fc-Glycosylation influences Fcg receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12. J Immunol. 2010;185(11):6876\u201382.","journal-title":"J Immunol"},{"issue":"2","key":"811_CR150","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1467-7652.2007.00306.x","volume":"6","author":"T Rademacher","year":"2008","unstructured":"Rademacher T, Sack M, Arcalis E, Stadlmann J, Balzer S, Altmann F, et al. Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotechnol J. 2008;6(2):189\u2013201.","journal-title":"Plant Biotechnol J"},{"issue":"7","key":"811_CR151","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02465-16","volume":"61","author":"C Zhao","year":"2017","unstructured":"Zhao C, Gunawardana M, Villinger F, Baum MM, Remedios-Chan M, Moench TR, et al. Pharmacokinetics and preliminary safety of pod-intravaginal rings delivering the monoclonal antibody VRC01-N for HIV prophylaxis in a macaque model. Antimicrob Agents Chemother. 2017;61(7):e02465-16.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"811_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63052-1","volume":"10","author":"AA Singh","year":"2020","unstructured":"Singh AA, Pooe O, Kwezi L, Lotter-Stark T, Stoychev SH, Alexandra K, et al. Plant-based production of highly potent anti-HIV antibodies with engineered posttranslational modifications. Sci Rep. 2020;10(1):6201.","journal-title":"Sci Rep"},{"issue":"1","key":"811_CR153","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-021-00560-6","volume":"18","author":"CM Moore","year":"2021","unstructured":"Moore CM, Grandits M, Grunwald-Gruber C, Altmann F, Kotouckova M, Teh AYH, et al. Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants. Retrovirology. 2021;18(1):17.","journal-title":"Retrovirology"},{"issue":"31","key":"811_CR154","doi-asserted-by":"publisher","first-page":"20479","DOI":"10.1074\/jbc.M109.014126","volume":"284","author":"R Strasser","year":"2009","unstructured":"Strasser R, Castilho A, Stadlmann J, Kunert R, Quendler H, Gattinger P, et al. Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous b1,4-galactosylated N-glycan profile. J Biol Chem. 2009;284(31):20479\u201385.","journal-title":"J Biol Chem"},{"issue":"41","key":"811_CR155","doi-asserted-by":"publisher","first-page":"12675","DOI":"10.1073\/pnas.1509090112","volume":"112","author":"A Loos","year":"2015","unstructured":"Loos A, Gach J, Hackl T, Maresch D, Henkel T, Porodko A, et al. Glycan modulation and sulfoengineering of anti-HIV-1 monoclonal antibody PG9 in plants. Proc Natl Acad Sci USA. 2015;112(41):12675\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"811_CR156","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1096\/fj.09-131995","volume":"23","author":"A Sexton","year":"2009","unstructured":"Sexton A, Harman S, Shattock RJ, Ma JKC. Design, expression, and characterization of a multivalent, combination HIV microbicide. FASEB J. 2009;23(10):3590\u2013600.","journal-title":"FASEB J"},{"issue":"8","key":"811_CR157","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/pbi.13090","volume":"17","author":"L Kasinger","year":"2019","unstructured":"Kasinger L, Dent M, Mahajan G, Homorsky K, Matoba N. A novel anti-HIV-1 bispecific bNAb-lectin fusion protein engineered in a plant-based transient expression system. Plant Biotechnol J. 2019;17(8):1646\u201356.","journal-title":"Plant Biotechnol J"},{"issue":"3","key":"811_CR158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120451","volume":"10","author":"Y Rosenberg","year":"2015","unstructured":"Rosenberg Y, Sack M, Montefiori D, Labranche C, Lewis M, Urban L, et al. Pharmacokinetics and immunogenicity of broadly neutralizing HIV monoclonal antibodies in macaques. PLoS ONE. 2015;10(3):e0120451.","journal-title":"PLoS ONE"},{"issue":"8","key":"811_CR159","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/pbi.12416","volume":"13","author":"J Ma","year":"2015","unstructured":"Ma J, Drossard J, Lewis D, Altmann F, Boyle J, Christou P, et al. Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants. Plant Biotechnol J. 2015;13(8):1106\u201320.","journal-title":"Plant Biotechnol J"},{"issue":"2","key":"811_CR160","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/infdis\/165.2.251","volume":"165","author":"EW Hook III","year":"1992","unstructured":"Hook EW III, Cannon RO, Nahmias AJ, Lee FF, Campbell CH Jr, Glasser D, et al. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals [see comments]. J Infect Dis. 1992;165(2):251\u20135.","journal-title":"J Infect Dis"},{"issue":"13","key":"811_CR161","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/4344","volume":"16","author":"L Zeitlin","year":"1998","unstructured":"Zeitlin L, Olmsted SS, Moench TR, Co MS, Martinell BJ, Paradkar VM, et al. A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes. Nat Biotechnol. 1998;16(13):1361\u20134.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"811_CR162","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003495","volume":"18","author":"JA Politch","year":"2021","unstructured":"Politch JA, Cu-Uvin S, Moench TR, Tashima KT, Marathe JG, Guthrie KM, et al. Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): a phase I randomized trial. PLoS Med. 2021;18(2):e1003495.","journal-title":"PLoS Med"},{"key":"811_CR163","doi-asserted-by":"publisher","first-page":"1607403","DOI":"10.3389\/fpls.2025.1607403","volume":"16","author":"S Tengattini","year":"2025","unstructured":"Tengattini S, Tini A, Marusic C, Rinaldi F, Senini I, Calleri E, et al. Plant-related quality attributes affecting FcgammaRIIIa binding: affinity chromatography analysis of rituximab glycovariants from Nicotiana benthamiana. Front Plant Sci. 2025;16:1607403. https:\/\/doi.org\/10.3389\/fpls.2025.1607403.","journal-title":"Front Plant Sci"},{"key":"811_CR164","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010194","volume":"20","author":"V Kommineni","year":"2019","unstructured":"Kommineni V, Markert M, Ren Z, Palle S, Carrillo B, Deng J, et al. In vivo glycan engineering via the mannosidase I inhibitor (Kifunensine) improves efficacy of rituximab manufactured in Nicotiana benthamiana plants. Int J Mol Sci. 2019;20:194.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"811_CR165","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017541","volume":"6","author":"T Komarova","year":"2011","unstructured":"Komarova T, Kosorukov V, Frolova O, Petrunia I, Skrypnik K, Gleba Y, et al. Plant-made trastuzumab (Herceptin) inhibits HER2\/Neu+ cell proliferation and retards tumor growth. PLoS ONE. 2011;6(3):e17541.","journal-title":"PLoS ONE"},{"issue":"25","key":"811_CR166","doi-asserted-by":"publisher","first-page":"16126","DOI":"10.1021\/acsnano.4c00360","volume":"18","author":"C Park","year":"2024","unstructured":"Park C, Kim K, Kim Y, Zhu R, Hain L, Seferovic H, et al. Plant-derived anti-human epidermal growth factor receptor 2 antibody suppresses trastuzumab-resistant breast cancer with enhanced nanoscale binding. ACS Nano. 2024;18(25):16126\u201340.","journal-title":"ACS Nano"},{"issue":"1","key":"811_CR167","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52507-9","volume":"9","author":"T Komarova","year":"2019","unstructured":"Komarova T, Sheshukova E, Kosobokova E, Kosorukov V, Shindyapina A, Lipskerov F, et al. The biological activity of bispecific trastuzumab\/pertuzumab plant biosimilars may be drastically boosted by disulfiram increasing formaldehyde accumulation in cancer cells. Sci Rep. 2019;9(1):16168.","journal-title":"Sci Rep"},{"issue":"3","key":"811_CR168","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/bit.26503","volume":"115","author":"C Marusic","year":"2018","unstructured":"Marusic C, Pioli C, Steler S, Novelli F, Lonoce C, Morrocchi E, et al. N-glycan engineering of a plant-produced anti-CD20-hIL-2 immunocytokine significantly enhances its effector functions. Biotechnol Bioeng. 2018;115(3):565\u201376.","journal-title":"Biotechnol Bioeng"},{"key":"811_CR169","unstructured":"Chen Q, Yang M, Sun H, Lai H. A plant produced anti-EGFR mAbs with specific glycosylation to improve the efficacy against cancer. US Patent Application 20,240,239,905 A1. 2024."},{"key":"811_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210045","volume":"24","author":"M Stark","year":"2023","unstructured":"Stark M, Joubert A, Visagie M. Molecular farming of Pembrolizumab and Nivolumab. Int J Mol Sci. 2023;24:10045. https:\/\/doi.org\/10.3390\/ijms241210045.","journal-title":"Int J Mol Sci"},{"key":"811_CR171","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2021.736299","volume":"12","author":"T Phakham","year":"2021","unstructured":"Phakham T, Bulaon CJI, Khorattanakulchai N, Shanmugaraj B, Buranapraditkun S, Boonkrai C, et al. Functional characterization of pembrolizumab produced in Nicotiana benthamiana using a rapid transient expression system. Front Plant Sci. 2021;12:736299. https:\/\/doi.org\/10.3389\/fpls.2021.736299.","journal-title":"Front Plant Sci"},{"key":"811_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.btre.2025.e00927","volume":"48","author":"C Bulaon","year":"2025","unstructured":"Bulaon C, Janejira J, Rattanapisit K, Suwanchaikasem P, Guo S, Boonha K, et al. Glycoengineering of plant-produced Pembrolizumab enhances FcRn binding and extends serum half-life in mice. Biotechnol Rep. 2025;48:e00927.","journal-title":"Biotechnol Rep"},{"key":"811_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.btre.2023.e00794","volume":"38","author":"C Bulaon","year":"2023","unstructured":"Bulaon C, Sun H, Malla A, Phoolcharoen W. Therapeutic efficacy of plant-produced Nivolumab in transgenic C57BL\/6-hPD-1 mouse implanted with MC38 colon cancer. Biotechnol Rep. 2023;38:e00794.","journal-title":"Biotechnol Rep"},{"issue":"1","key":"811_CR174","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-41510-w","volume":"13","author":"K Rattanapisit","year":"2023","unstructured":"Rattanapisit K, Bulaon C, Strasser R, Sun H, Phoolcharoen W. In vitro and in vivo studies of plant-produced Atezolizumab as a potential immunotherapeutic antibody. Sci Rep. 2023;13(1):14146.","journal-title":"Sci Rep"},{"issue":"5","key":"811_CR175","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/pbi.14260","volume":"22","author":"S Izadi","year":"2024","unstructured":"Izadi S, Gumpelmair S, Coelho R, Duarte H, Gomes J, Leiner J, et al. Plant-derived Durvalumab variants show efficient PD-1\/PD-L1 blockade and therapeutically favourable FcR binding. Plant Biotechnol J. 2024;22(5):1224\u201337.","journal-title":"Plant Biotechnol J"},{"issue":"4","key":"811_CR176","doi-asserted-by":"publisher","DOI":"10.1007\/s00299-025-03475-0","volume":"44","author":"S Izadi","year":"2025","unstructured":"Izadi S, Abrantes R, Gumpelmair S, Kunnummel V, Duarte H, Steinberger P, et al. An engineered PD1-Fc fusion produced in N. benthamiana plants efficiently blocks PD1\/PDL1 interaction. Plant Cell Rep. 2025;44(4):80.","journal-title":"Plant Cell Rep"},{"key":"811_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2023.1149455","volume":"14","author":"C Bulaon","year":"2023","unstructured":"Bulaon C, Khorattanakulchai N, Rattanapisit K, Sun H, Pisuttinusart N, Phoolcharoen W. Antitumor effect of plant-produced anti-CTLA-4 monoclonal antibody in a murine model of colon cancer. Front Plant Sci. 2023;14:1149455. https:\/\/doi.org\/10.3389\/fpls.2023.1149455.","journal-title":"Front Plant Sci"},{"issue":"04","key":"811_CR178","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1055\/a-2240-7534","volume":"90","author":"C Bulaon","year":"2024","unstructured":"Bulaon C, Khorattanakulchai N, Rattanapisit K, Sun H, Pisuttinusart N, Phoolcharoen W. Development of plant-derived bispecific monoclonal antibody targeting PD-L1 and CTLA-4 against mouse colorectal cancer. Planta Med. 2024;90(04):305\u201315.","journal-title":"Planta Med"},{"issue":"3","key":"811_CR179","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4161\/hv.7.3.14163","volume":"7","author":"A McCormick","year":"2011","unstructured":"McCormick A. Tobacco derived cancer vaccines for non-Hodgkin\u2019s lymphoma: perspectives and progress. Hum Vaccin Immunother. 2011;7(3):305\u201312.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"811_CR180","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1073\/pnas.96.2.703","volume":"96","author":"A McCormick","year":"1999","unstructured":"McCormick A, Kumagai M, Hanley K, Turpen T, Kakim I, Grill L, et al. Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants. Proc Natl Acad Sci USA. 1999;96(2):703\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1-2","key":"811_CR181","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0022-1759(03)00208-4","volume":"278","author":"A McCormick","year":"2003","unstructured":"McCormick A, Reinl S, Cameron T, Vojdani F, Fronefield M, Levy R, et al. Individualized human scFv vaccines produced in plants: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig. J Immunol Methods. 2003;278(1\u20132):95\u2013104.","journal-title":"J Immunol Methods"},{"issue":"29","key":"811_CR182","doi-asserted-by":"publisher","first-page":"10131","DOI":"10.1073\/pnas.0803636105","volume":"105","author":"A McCormick","year":"2008","unstructured":"McCormick A, Reddy S, Reinl S, Cameron T, Czerwinkski D, Vojdani F, et al. Plant-produced idiotype vaccines for the treatment of non-Hodgkin\u2019s lymphoma: safety and immunogenicity in a phase I clinical study. Proc Natl Acad Sci USA. 2008;105(29):10131\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"811_CR183","volume":"2015","author":"D Tus\u00e9","year":"2015","unstructured":"Tus\u00e9 D, Ku N, Bendandi M, Becerra C, Collins R, Lanford N, et al. Clinical safety and immunogenicity of tumor-targeted, plant-made Id-KLH conjugate vaccines for follicular lymphoma. Biomed Res Int. 2015;2015(1):648143.","journal-title":"Biomed Res Int"},{"issue":"22","key":"811_CR184","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1056\/NEJMoa2201300","volume":"386","author":"KJ Hager","year":"2022","unstructured":"Hager KJ, Perez Marc G, Gobeil P, Diaz RS, Heizer G, Llapur C, et al. Efficacy and safety of a recombinant plant-based adjuvanted Covid-19 vaccine. N Engl J Med. 2022;386(22):2084\u201396. https:\/\/doi.org\/10.1056\/NEJMoa2201300.","journal-title":"N Engl J Med"},{"key":"811_CR185","doi-asserted-by":"publisher","first-page":"1633104","DOI":"10.3389\/fgeed.2025.1633104","volume":"7","author":"M Rafi","year":"2025","unstructured":"Rafi M, Elsiddig M, Aldarmaki M, Nuaimi M, George S, Amiri K. Application of a multiplex CRISPR\/Cas9 strategy for elimination of selection markers from transgenic plants. Front Genome Ed. 2025;7:1633104.","journal-title":"Front Genome Ed."},{"issue":"10","key":"811_CR186","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.tibtech.2013.06.002","volume":"31","author":"A Magnusdottir","year":"2013","unstructured":"Magnusdottir A, Vidarsson H, Bjornsson J, Orvar B. Barley grains for the production of endotoxin-free growth factors. Trends Biotechnol. 2013;31(10):572\u201380.","journal-title":"Trends Biotechnol"},{"issue":"13","key":"811_CR187","doi-asserted-by":"publisher","first-page":"8013","DOI":"10.1073\/pnas.0832472100","volume":"100","author":"K Ko","year":"2003","unstructured":"Ko K, Tekoah Y, Rudd P, Harvey D, Dwek R, Spitsin S, et al. Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc Natl Acad Sci USA. 2003;100(13):8013\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"811_CR188","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11081377","volume":"11","author":"B Lumlertdacha","year":"2023","unstructured":"Lumlertdacha B, Mahong B, Rattanapisit K, Bulaon CJI, Hemachudha T, Phoolcharoen W. Efficiency comparative approach of plant-produced monoclonal antibodies against rabies virus infection. Vaccines (Basel). 2023;11(8):1377. https:\/\/doi.org\/10.3390\/vaccines11081377.","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"811_CR189","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4161\/mabs.23281","volume":"5","author":"L Zeitlin","year":"2013","unstructured":"Zeitlin L, Bohorov O, Bohorova N, Hiatt A, Kim D, Pauly M, et al. Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model. MAbs. 2013;5(2):263\u20139.","journal-title":"MAbs"},{"issue":"1","key":"811_CR190","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2327142","volume":"20","author":"N Pisuttinusart","year":"2024","unstructured":"Pisuttinusart N, Rattanapisit K, Srisaowakarn C, Thitithanyanont A, Strasser R, Shanmugaraj B, et al. Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana. Hum Vaccin Immunother. 2024;20(1):2327142. https:\/\/doi.org\/10.1080\/21645515.2024.2327142.","journal-title":"Hum Vaccin Immunother"}],"container-title":["BioDrugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-026-00811-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40259-026-00811-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-026-00811-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:03:10Z","timestamp":1789689790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40259-026-00811-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":190,"alternative-id":["811"],"URL":"https:\/\/doi.org\/10.1007\/s40259-026-00811-y","relation":{},"ISSN":["1173-8804","1179-190X"],"issn-type":[{"value":"1173-8804","type":"print"},{"value":"1179-190X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"5 September 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No new datasets were generated or analyzed for this review; all information was derived from previously published sources cited in the article.","order":5,"name":"Ethics","label":"Availability of data and materials","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Qiang Chen: conceptualization; literature review; writing\u2014original draft; writing\u2014review and editing. The author read and approved the final manuscript.","order":7,"name":"Ethics","label":"Author\u2019s contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}